Sandip Kapadia

CIK 1677141 · CHIEF FINANCIAL OFFICER · last filed 2026-05-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$845.0K

Companies

3

Total Filings

45

Lifetime Open-Market Net

-$4.11M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PASG Director 0 $5.81 $0 $84.0K 9 2026-05-21
HRMY CHIEF FINANCIAL OFFICER 24,521 $34.46 $845.0K -$3.89M 17 2026-01-28
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted CFO and Treasurer 40,964 $19.00 $778.3K -$306.3K 19 2021-01-26

Recent Filings · Page 2 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-04-01 HRMY Mixed +6,986 -$266.0K EDGAR
2025-01-28 HRMY Mixed -$145.0K EDGAR
2025-01-23 HRMY Mixed -$278.8K EDGAR
2024-10-02 HRMY Mixed +27,948 -$1.28M EDGAR
2024-05-23 PASG Grant (A) $0 EDGAR
2024-04-02 HRMY Mixed +6,987 -$269.1K EDGAR
2024-01-26 HRMY Grant (A) $0 EDGAR
2023-11-08 HRMY Grant (A) $0 EDGAR
2023-05-26 PASG Grant (A) $0 EDGAR
2023-03-31 HRMY Mixed +14,586 -$514.2K EDGAR
Showing 1120 of 45
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.